Richard Harris

Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.

Harris has traveled to all seven continents for NPR. His reports have originated from Timbuktu, the South Pole, the Galapagos Islands, Beijing during the SARS epidemic, the center of Greenland, the Amazon rain forest, the foot of Mt. Kilimanjaro (for a story about tuberculosis), and Japan to cover the nuclear aftermath of the 2011 tsunami.
In 2010, Harris' reporting revealed that the blown-out BP oil well in the Gulf of Mexico was spewing out far more oil than asserted in the official estimates. That revelation led the federal government to make a more realistic assessment of the extent of the spill.

Harris covered climate change for decades. He reported from the United Nations climate negotiations, starting with the Earth Summit in Rio de Janeiro in 1992, and including Kyoto in 1997 and Copenhagen in 2009. Harris was a major contributor to NPR's award-winning 2007-2008 "Climate Connections" series.

Over the course of his career, Harris has been the recipient of many prestigious awards. Those include the American Geophysical Union's 2013 Presidential Citation for Science and Society. He shared the 2009 National Academy of Sciences Communication Award and was a finalist again in 2011. In 2002, Harris was elected an honorary member of Sigma Xi, the scientific research society. Harris shared a 1995 Peabody Award for investigative reporting on NPR about the tobacco industry. Since 1988, the American Association for the Advancement of Science has honored Harris three times with its science journalism award.

Before joining NPR, Harris was a science writer for the San Francisco Examiner. From 1981 to 1983, Harris was a staff writer at The Tri-Valley Herald in Livermore, California, covering science, technology, and health issues related to the nuclear weapons lab in Livermore. He started his career as an AAAS Mass Media Science Fellow at the now-defunct Washington (DC) Star.

Harris is co-founder of the Washington, D.C., Area Science Writers Association, and is past president of the National Association of Science Writers. He serves on the board of the Council for the Advancement of Science Writing.

A California native, Harris returned to the University of California-Santa Cruz in 2012, to give a commencement address at Crown College, where he had given a valedictory address at his own graduation. He earned a bachelor's degree at the school in biology, with highest honors.

Pages

Shots - Health News
4:52 am
Mon September 15, 2014

Patients Vulnerable When Cash-Strapped Scientists Cut Corners

Tom Murphy, 56, in his home in Gainesville, Va., was diagnosed with ALS four years ago. An experimental drug seems to have slowed the progression of his disease, he says, though most ALS patients aren't as lucky.
T.J. Kirkpatrick for NPR

Originally published on Tue September 16, 2014 9:09 am

There's a funding crunch for biomedical research in the United States — and it's not just causing pain for scientists and universities. It's also creating incentives for researchers to cut corners — and that's affecting people who are seriously ill.

Read more
Research News
5:10 am
Wed September 10, 2014

Built In Better Times, University Labs Now Lack Research Funding

Originally published on Wed September 10, 2014 8:01 am

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Shots - Health News
4:58 pm
Tue September 9, 2014

When Scientists Give Up

Randen Patterson left a research career in physiology at U.C. Davis when funding got too tight. He now owns a grocery store in Guinda, Calif.
Max Whittaker/Prime for NPR

Originally published on Wed September 10, 2014 3:29 pm

Ian Glomski thought he was going to make a difference in the fight to protect people from deadly anthrax germs. He had done everything right — attended one top university, landed an assistant professorship at another.

But Glomski ran head-on into an unpleasant reality: These days, the scramble for money to conduct research has become stultifying.

So, he's giving up on science.

Read more
Shots - Health News
3:29 am
Tue September 9, 2014

U.S. Science Suffering From Booms And Busts In Funding

Leif Parsons for NPR

Originally published on Tue September 16, 2014 6:43 pm

Ten years ago, Robert Waterland got an associate professorship at Baylor College of Medicine and set off to study one of the nation's most pressing health problems: obesity. In particular, he's been trying to figure out the biology behind why children born to obese women are more likely to develop the condition themselves.

Waterland got sustaining funding from the National Institutes of Health and used it to get the project going.

Read more
Goats and Soda
5:24 pm
Fri August 15, 2014

Even With $100 Million, WHO Says It Will Take Months To Control Ebola

A health worker cleans his hands with chlorinated water before entering an Ebola screening tent at the Kenema Government Hospital in Sierra Leone. More than 300 Sierra Leoneans have died of the disease.
Michael Duff AP

Originally published on Fri August 15, 2014 9:50 pm

When public health officials warn that it's likely to take many months to bring the Ebola outbreak in West Africa under control, it's not because they're facing a single huge challenge.

"If there was just one solid, large chunk we could slice out, we would," says WHO spokeswoman Nyka Alexander, at the agency's regional coordination center in Conakry, Guinea. "But it's so many little things that add up to the outbreak."

Read more
Global Health
5:27 am
Tue August 12, 2014

Why Is There No Drug To Treat Ebola?

Originally published on Tue August 12, 2014 7:42 am

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Transcript

STEVE INSKEEP, HOST:

Read more
Shots - Health News
1:16 pm
Fri August 8, 2014

Investors Pump Prospects Of Unproven Ebola Treatments

Tobacco plants grown at an Owensboro, Ky., biotechnology firm were used to help produce an experimental serum used to treat two Americans infected with Ebola.
AP

Originally published on Fri August 8, 2014 1:24 pm

Interest in drugs that might be used to treat Ebola virus has hit a fever pitch, but the buzz isn't simply about fear of Ebola, or about saving lives in poor nations of West Africa. It's also about money.

Read more
Shots - Health News
7:03 am
Sat August 2, 2014

Why Treating Ebola With An Experimental Serum Might Help

In 1995, amid an Ebola outbreak, Zairian Red Cross personnel picked up sick people and bodies left on the streets of Kikwit, 250 miles from the capital Kinshasa.
Jean-Marc Bouju AP

Originally published on Mon August 25, 2014 11:23 am

Last week we learned that two Americans working in Liberia for a medical charity, Samaritan's Purse, were among those who had contracted Ebola. When their symptoms took a turn for the worse, the organization announced that the two were going to get experimental treatments. One was going to get a blood transfusion from a 14-year-old boy who recovered from the disease, the organization said; the other was to get an "experimental serum." What's that?

Read more
Shots - Health News
6:38 pm
Fri July 11, 2014

Feds Tighten Lab Security After Anthrax, Bird Flu Blunders

Particles of H5N1 virus — a particularly dangerous type of bird flu that can infect people — attack lung cells.
Chris Bjornberg Science Source

Originally published on Fri July 11, 2014 8:21 pm

In the course of trying to understand a laboratory accident involving anthrax, officials at the Centers for Disease Control and Prevention stumbled upon another major blunder — involving a deadly flu virus.

Read more
Business
4:11 pm
Fri July 11, 2014

Declining Domestic Sales Speed Talks For Tobacco Mega-Merger

Originally published on Sun July 13, 2014 1:03 am

Transcript

MELISSA BLOCK, HOST:

From NPR News, this is ALL THINGS CONSIDERED. I'm Melissa Block. The U.S. tobacco industry could be in for a shakeup. Reynolds American, the maker of cigarette brands such as Camel and Pall Mall, confirmed today that it's in talks to buy its smaller rival, Lorillard. As NPR's Yuki Noguchi reports, the potential merger comes as the industry feels the pinch of declining sales.

Read more

Pages